Olive Leaf Extracts in the Control of Diabet
Recruiting · NCT05605704 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Monastir
View the official record on ClinicalTrials.gov →Interventions studied
AtherolivePlacebo Atherolive
What this trial is about
This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: -Diabets
Who can take part
Age range
18 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2, Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients over 18 years of age with:
- diabetes.
Exclusion criteria
- Exclusion criteria: None.
Where it is running
1 location listed.
- Semir Nouira - Monastir, Monastir Tunisia, Tunisia